NOVARTIS AG : marks 30 year anniversary in transplantation and reinforces ... 4-traders (press release) The study of more than 2,000 patients will investigate de novo Certican + low dose CNI versus Mycophenolic Acid (MPA) + standard CNI, evaluating renal function and graft outcomes at 12- and 24- months, as well as long-term outcomes up to five years ... |
